{
  "id": "nclex-ngn-sa-ps-2026-041",
  "itemType": "standalone_multipleChoice",
  "prompt": "The nurse is reviewing the electronic health record for a client in the emergency department. Based on the provided information, which action should the nurse perform first?",
  "stem": {
    "sections": [
      {
        "type": "nursesNotes",
        "title": "Nurses' Notes",
        "content": "Client is a 68-year-old male with a history of end-stage renal disease (ESRD) on hemodialysis, hypertension, and type 2 diabetes mellitus. Arrived via ambulance with chief complaints of profound muscle weakness, palpitations, and nausea over the last 12 hours. Client is alert and oriented x3 but appears lethargic. Reports missing the last two scheduled hemodialysis appointments due to a lack of reliable transportation. A 20-gauge peripheral intravenous (PIV) catheter was placed in the left forearm by paramedics; it flushes sluggishly, and mild swelling is noted proximal to the site."
      },
      {
        "type": "table",
        "title": "Vital Signs Trend",
        "columns": [
          "Time",
          "BP",
          "HR",
          "RR",
          "Temp",
          "SpO2"
        ],
        "rows": [
          [
            "1300",
            "110/70",
            "62",
            "18",
            "37.0째C (98.6째F)",
            "97%"
          ],
          [
            "1330",
            "098/60",
            "54",
            "20",
            "37.1째C (98.8째F)",
            "96%"
          ]
        ]
      },
      {
        "type": "table",
        "title": "Laboratory Results",
        "columns": [
          "Test",
          "Result",
          "Reference Range"
        ],
        "rows": [
          [
            "Potassium",
            "7.1 mEq/L",
            "3.5-5.0 mEq/L"
          ],
          [
            "Creatinine",
            "8.9 mg/dL",
            "0.6-1.2 mg/dL"
          ],
          [
            "BUN",
            "95 mg/dL",
            "7-20 mg/dL"
          ],
          [
            "Troponin I",
            "<0.02 ng/mL",
            "<0.04 ng/mL"
          ]
        ]
      },
      {
        "type": "text",
        "title": "Diagnostic Findings",
        "content": "12-Lead ECG Interpretation: Sinus bradycardia with prominent peaked T waves, QRS duration of 0.14 seconds, and a PR interval of 0.22 seconds."
      },
      {
        "type": "text",
        "title": "Medication Administration Record (MAR)",
        "content": "STAT Orders:\n- Calcium gluconate 1 gram IV push over 5 minutes\n- Insulin, Regular 10 units IV push\n- Dextrose 50% 25 grams IV push\n- Sodium polystyrene sulfonate 30 grams orally"
      }
    ]
  },
  "options": [
    {
      "label": "D",
      "content": "Establish a new, large-bore peripheral IV line."
    },
    {
      "label": "A",
      "content": "Administer the prescribed calcium gluconate IV push."
    },
    {
      "label": "B",
      "content": "Administer the sodium polystyrene sulfonate orally."
    },
    {
      "label": "C",
      "content": "Prepare the regular insulin and D50W for administration."
    }
  ],
  "correctAnswer": "D",
  "rationale": {
    "correct": "The client is exhibiting signs of severe hyperkalemia, a life-threatening electrolyte imbalance, evidenced by the elevated potassium level (7.1 mEq/L) and the ECG findings (peaked T waves, widened QRS complex, bradycardia). These ECG changes indicate hyperkalemia-induced cardiotoxicity, which can rapidly progress to fatal arrhythmias like ventricular fibrillation or asystole. The priority intervention is to stabilize the cardiac membrane with calcium gluconate to counteract the effects of hyperkalemia on myocardial cells. However, the nurse's assessment reveals that the existing peripheral IV (PIV) is compromised, indicated by sluggish flushing and swelling proximal to the insertion site. This suggests potential infiltration or extravasation, meaning the IV is not patent and medication may leak into surrounding tissues instead of reaching the bloodstream. Calcium gluconate is a vesicant, meaning it can cause severe tissue damage and necrosis if it extravasates. Therefore, the *absolute* first action is to establish a new, reliable, large-bore IV line to ensure safe and effective administration of calcium gluconate and other emergency medications. Delaying this step and attempting to administer medications through the compromised IV poses a significant risk of tissue injury and treatment failure.",
    "incorrect": "This question requires the nurse to prioritize interventions based on both physiological needs and safety considerations. While addressing the hyperkalemia is crucial, the compromised IV access presents an immediate safety risk that must be resolved first. The other options represent appropriate interventions for hyperkalemia but are not the *first* action due to the IV access issue.",
    "answerBreakdown": [
      {
        "label": "A",
        "content": "Administering calcium gluconate is a correct pharmacological intervention to stabilize the myocardium in hyperkalemia. Calcium gluconate increases the threshold potential of cardiac cells, making them less excitable and less prone to arrhythmias. However, administering it through a potentially infiltrated IV is extremely dangerous due to the risk of extravasation and tissue necrosis. This is an unsafe action.",
        "isCorrect": false
      },
      {
        "label": "B",
        "content": "Sodium polystyrene sulfonate (Kayexalate) is a potassium-binding resin that promotes potassium excretion through the gastrointestinal tract. While it helps lower potassium levels, its onset of action is slow (hours), making it unsuitable for treating acute, life-threatening hyperkalemia. Immediate interventions are needed to stabilize the heart and shift potassium intracellularly.",
        "isCorrect": false
      },
      {
        "label": "C",
        "content": "Administering IV insulin and dextrose is the next step after myocardial stabilization. Insulin promotes the movement of potassium from the extracellular to the intracellular space, thereby lowering serum potassium levels. Dextrose is given to prevent hypoglycemia from the insulin. While crucial, this action is secondary to administering calcium and also requires a patent IV line, which is not currently available.",
        "isCorrect": false
      },
      {
        "label": "D",
        "content": "This is the correct first action. All prescribed STAT intravenous medications (calcium gluconate, insulin, dextrose) require a reliable, patent IV line for safe and effective administration. Recognizing that the current IV access is compromised and taking action to correct this foundational problem is the nurse's immediate priority to ensure patient safety before any medications can be given. A large-bore IV (18 gauge or larger) is preferred to allow for rapid infusion of medications.",
        "isCorrect": true
      }
    ]
  },
  "pedagogy": {
    "bloomLevel": "Analyze",
    "cjmmStep": "Take Actions",
    "nclexCategory": "Management of Care",
    "nclexSubcategory": "Establishing Priorities",
    "difficulty": "Level 5 (Highly Discriminating)",
    "topicTags": [
      "Hyperkalemia",
      "IV Therapy",
      "Medication Safety",
      "Chronic Kidney Disease",
      "Electrolyte Imbalance",
      "Patient Safety",
      "Social Determinants of Health"
    ]
  },
  "clinicalPearls": [
    "Compromised IV access is a critical 'Safety Stop' that must be addressed *before* administering potentially harmful medications, especially vesicants like calcium gluconate. Always assess IV patency before administering medications.",
    "In hyperkalemia, ECG changes like peaked T waves, widened QRS, and bradycardia indicate severe cardiotoxicity requiring immediate intervention. Prioritize interventions based on the severity of ECG changes.",
    "Social determinants of health, such as lack of reliable transportation, can significantly impact a client's ability to adhere to treatment plans and lead to life-threatening complications. Consider involving social work to address these barriers.",
    "The pathophysiology of hyperkalemia involves the disruption of the normal resting membrane potential of cells, particularly cardiac cells. The elevated extracellular potassium concentration reduces the concentration gradient, leading to partial depolarization. This makes the cells more excitable initially (peaked T waves) but eventually leads to impaired repolarization and conduction delays (widened QRS, prolonged PR interval, bradycardia), increasing the risk of fatal arrhythmias."
  ],
  "sbar": {
    "situation": "1330: 68-year-old male with ESRD, hypertension, and type 2 diabetes presenting with profound muscle weakness, palpitations, and nausea.  Missed last two hemodialysis appointments due to transportation issues.",
    "background": "History of ESRD on hemodialysis, hypertension, and type 2 diabetes.  Arrived via ambulance.  Current IV is sluggish and has swelling.",
    "assessment": "Alert and oriented x3 but lethargic.  Vital signs: BP 098/60, HR 54, RR 20. Labs show severe hyperkalemia (7.1 mEq/L), elevated creatinine (8.9 mg/dL) and BUN (95 mg/dL). ECG shows sinus bradycardia with peaked T waves and widened QRS.  Current IV is compromised.",
    "recommendation": "Establish a new, large-bore peripheral IV line immediately.  Anticipate orders for calcium gluconate, insulin, and dextrose to treat hyperkalemia.  Address the client's transportation issues to ensure future hemodialysis appointments are kept. Consult social work. Continuous cardiac monitoring is essential."
  },
  "sentinelStatus": "healed_v2026_v8"
}